BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baig S, Paisey R, Dawson C, Barrett T, Maffei P, Hodson J, Rambhatla SB, Chauhan P, Bolton S, Dassie F, Francomano C, Marshall RP, Belal M, Skordilis K, Hayer M, Price AM, Cramb R, Edwards N, Steeds RP, Geberhiwot T. Defining renal phenotype in Alström syndrome. Nephrol Dial Transplant 2020;35:994-1001. [PMID: 30307515 DOI: 10.1093/ndt/gfy293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Adeva-Andany MM, Carneiro-Freire N. Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes 2022; 13(7): 498-520 [DOI: 10.4239/wjd.v13.i7.498] [Reference Citation Analysis]
2 Choudhury AR, Munonye I, Sanu KP, Islam N, Gadaga C. A review of Alström syndrome: a rare monogenic ciliopathy. Intractable Rare Dis Res 2021;10:257-62. [PMID: 34877237 DOI: 10.5582/irdr.2021.01113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zacchia M, Blanco FDV, Torella A, Raucci R, Blasio G, Onore ME, Marchese E, Trepiccione F, Vitagliano C, Iorio VD, Alessandra P, Simonelli F, Nigro V, Capasso G, Viggiano D. Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients. Clin Kidney J 2021;14:1545-51. [PMID: 34084454 DOI: 10.1093/ckj/sfaa182] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Tahani N, Maffei P, Dollfus H, Paisey R, Valverde D, Milan G, Han JC, Favaretto F, Madathil SC, Dawson C, Armstrong MJ, Warfield AT, Düzenli S, Francomano CA, Gunay-Aygun M, Dassie F, Marion V, Valenti M, Leeson-Beevers K, Chivers A, Steeds R, Barrett T, Geberhiwot T. Consensus clinical management guidelines for Alström syndrome. Orphanet J Rare Dis 2020;15:253. [PMID: 32958032 DOI: 10.1186/s13023-020-01468-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
5 Grochowsky A, Gunay-Aygun M. Clinical characteristics of individual organ system disease in non-motile ciliopathies. Transl Sci Rare Dis 2019;4:1-23. [PMID: 31763176 DOI: 10.3233/TRD-190033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
6 Eneli I, Xu J, Webster M, McCagg A, Van Der Ploeg L, Garfield AS, Estrada E. Tracing the effect of the melanocortin-4 receptor pathway in obesity: study design and methodology of the TEMPO registry. Appl Clin Genet 2019;12:87-93. [PMID: 31239751 DOI: 10.2147/TACG.S199092] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]